With 9 years of experience in the PFS and combination products market, we are excited to announce the 9th edition Injectables Summit, returning to San Diego in September.

Expected to reach US $932m by 2025 with a CAGR of 11% between now and then, drug and device developers are racing for the best injectable devices to deliver better care for patients and HCPs.  Breakthroughs in both science and technology fuel the fierce competition in the space - from highly concentrated subcutaneous delivery to wearable devices, from advanced therapy medicinal product injections to a connected digital device that offers the opportunity of remote monitoring and precise injection.